• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗真菌药物(伊曲康唑)在乳腺癌患者化疗引起的口腔黏膜炎中的应用价值]

[Usefulness of antimycotic agents (itraconazole) in chemotherapy-induced mucositis of breast cancer patients].

作者信息

Tsuyuki Shigeru, Kawaguchi Kosuke, Kawata Yukiko, Yamaguchi Ayane, Kanazawa Akiyoshi, Sugitatsu Mitsuchika, Kono Yukihiro

机构信息

Dept. of Breast and General Surgery, Osaka Red Cross Hospital.

出版信息

Gan To Kagaku Ryoho. 2012 Sep;39(9):1369-73.

PMID:22996771
Abstract

Chemotherapy-induced oral mucositis is a common adverse event in breast cancer patients. Breakdown of the mucosal barrier predisposes the patient to bacterial, fungal and viral superinfection, especially candidiasis. We demonstrated the frequency of chemotherapy-induced oral mucositis and oral candidiasis, and the efficacy of antimycotic agents in breast cancer patients. We investigated 32 patients with advanced and metastatic breast cancer who underwent chemotherapy in our department from March, 2009 to August, 2010. The chemotherapy regimens were as follows: FEC (epirubicin/5-FU/cyclophosphamide) followed by taxanes: 21, FEC: 1, TC (docetaxel/cyclophosphamide): 7, DOC (docetaxel): 3, and CPT-11/S-1: 1. Patients had blood and bacteria tests of the oral cavity at the time mucositis symptoms appeared. We administered an antimycotic agent (itraconazole) and evaluated its effect on mucositis at the time mucositis symptoms appeared. 56. 3% of patients had chemotherapy-induced oral mucositis, and 38. 9% of the mucositis patients had oral candidiasis. The incidence of mucositis increased when severe neutropenia occurred. 92. 9% of mucositis patients were cured or improved by itraconazole. In conclusion, chemotherapy caused oral candidiasis in 40% of cases with oral mucositis, and in about 56% of breast cancer patients. The antimycotic agent may be useful for chemotherapy-induced oral mucositis in breast cancer patients.

摘要

化疗引起的口腔黏膜炎是乳腺癌患者常见的不良事件。黏膜屏障的破坏使患者易发生细菌、真菌和病毒的二重感染,尤其是念珠菌病。我们证实了化疗引起的口腔黏膜炎和口腔念珠菌病的发生率,以及抗真菌药物对乳腺癌患者的疗效。我们调查了2009年3月至2010年8月在我科接受化疗的32例晚期和转移性乳腺癌患者。化疗方案如下:FEC(表柔比星/5-氟尿嘧啶/环磷酰胺)序贯紫杉烷类:21例,FEC:1例,TC(多西他赛/环磷酰胺):7例,DOC(多西他赛):3例,CPT-11/S-1:1例。患者在出现黏膜炎症状时进行了血液和口腔细菌检测。在出现黏膜炎症状时,我们给予抗真菌药物(伊曲康唑)并评估其对黏膜炎的疗效。56.3%的患者发生了化疗引起的口腔黏膜炎,其中38.9%的黏膜炎患者合并口腔念珠菌病。严重中性粒细胞减少时黏膜炎的发生率增加。92.9%的黏膜炎患者经伊曲康唑治疗后治愈或好转。总之,化疗在40%的口腔黏膜炎病例中导致口腔念珠菌病,在约56%的乳腺癌患者中导致该病。抗真菌药物可能对化疗引起的乳腺癌患者口腔黏膜炎有用。

相似文献

1
[Usefulness of antimycotic agents (itraconazole) in chemotherapy-induced mucositis of breast cancer patients].[抗真菌药物(伊曲康唑)在乳腺癌患者化疗引起的口腔黏膜炎中的应用价值]
Gan To Kagaku Ryoho. 2012 Sep;39(9):1369-73.
2
Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients.高寒红景天改善乳腺癌患者化疗引起的口腔黏膜炎。
Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S91-100. doi: 10.1517/13543781003727057.
3
Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.头颈部癌放疗患者的口腔念珠菌分离株:患病率、唑类药物敏感性概况及对抗真菌治疗的反应
Oral Microbiol Immunol. 2004 Dec;19(6):347-51. doi: 10.1111/j.1399-302x.2004.00165.x.
4
Itraconazole for treatment of oral candidosis in pediatric cancer patients.伊曲康唑用于治疗儿科癌症患者的口腔念珠菌病。
J Med Assoc Thai. 1997 Jun;80(6):358-62.
5
[Therapeutic effect of rebamipide for oral mucositis associated with FEC therapy for breast cancer].瑞巴派特对乳腺癌FEC疗法相关口腔黏膜炎的治疗作用
Gan To Kagaku Ryoho. 2014 Nov;41(11):1407-12.
6
Prevention of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer).预防接受化疗的癌症患者(不包括头颈癌患者)发生口腔黏膜炎或口腔念珠菌病。
Cochrane Database Syst Rev. 2000(2):CD000978. doi: 10.1002/14651858.CD000978.
7
[High incidence-rate of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy (FEC100)].接受蒽环类药物化疗(FEC100)的乳腺癌患者口腔黏膜炎发病率高。
Gan To Kagaku Ryoho. 2012 Mar;39(3):395-8.
8
Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy.
Cytokines Cell Mol Ther. 1999 Dec;5(4):187-93.
9
Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients.乳腺癌患者辅助化疗引起的口腔黏膜病变、微生物变化及味觉障碍。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Aug;106(2):217-26. doi: 10.1016/j.tripleo.2008.04.003. Epub 2008 Jun 13.
10
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.局部应用粒细胞巨噬细胞集落刺激因子预防和治疗晚期头颈癌患者化疗及同步放化疗所致严重口腔黏膜炎的II期临床试验:有效性、安全性及成本评估
Oncol Rep. 2003 Jan-Feb;10(1):197-206.

引用本文的文献

1
Investigation on Molecular Mechanism of Fibroblast Regulation and the Treatment of Recurrent Oral Ulcer by Shuizhongcao Granule-Containing Serum.水菖蒲含药血清对口腔黏膜成纤维细胞调控作用及复发性口腔溃疡治疗机制的研究
Evid Based Complement Alternat Med. 2015;2015:324091. doi: 10.1155/2015/324091. Epub 2015 Oct 18.